1. Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers

   van Buel, E. M., Meddens, M. J. M., Arnoldussen, E. A., van den Heuvel, E. R., Bohlmeijer, W. C., den Boer, J. A., Muller Kobold, A., Boonman-de Winter, L. J. M., van Rumpt, D., Timmers, L. F. J., Veerman, M. F. A., Kamphuis, J. S., Gladkevich, A. V., Schoevers, R. A., Luiten, P. G. M., Eisel, U. L. M., Bosker, F. J. & Klein, H. C., 7-Aug-2019, In : Journal of Psychosomatic Research. 125, 109796.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis

   Fischer, R., Padutsch, T., Bracchi-Ricard, V., Murphy, K. L., Martinez, G. F., Delguercio, N., Elmer, N., Sendetski, M., Diem, R., Eisel, U. L. M., Smeyne, R. J., Kontermann, R. E., Pfizenmaier, K. & Bethea, J. R., 17-Jun-2019, In : Brain, Behavior, and Immunity.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Targeting TNFR2 as a novel therapeutic strategy for Alzheimer's disease

   Orti-Casan, N., Wu, Y., Naude, P. J. W., De Deyn, P. P., Zuhorn, I. S. & Eisel, U. L. M., 4-Feb-2019, In : Frontiers in Neuroscience. 13, 8 p., 49.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model

   Dekens, D. W., Naudé, P. J. W., Boerema, A. S., Keijser, J. N., De Deyn, P. P. & Eisel, U. L. M., 30-Nov-2018, In : Journal of neuroinflammation. 15, 13 p., 330.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

   Dong, Y., Dekens, D. W., De Deyn, P. P., Naude, P. J. W. & Eisel, U. L. M., Dec-2015, In : Antibodies. 4, 4, p. 369-408 40 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (119) »

1. Kan oogarts in de toekomst alzheimer diagnosticeren?

   Ulrich Eisel

   13/03/2019 → 20/03/2019

   1 item of media coverage, 1 media contribution

   Press/Media: Expert Comment › Popular

2. TNRR2 als een aangrijpingspunt voor de behandeling van MS

   Ulrich Eisel, Jon Laman & Wia Baron

   25/05/2016 → 20/05/2017

   2 items of media coverage

   Press/Media: Research › Professional

3. Selective manipulation of specific receptors may pave way for new MS therapies

   Yun Dong, Ulrich Eisel, Pieter Naudé, Csaba Nyakas, Eddy Zee, van der, Doortje Dekens & Wanda Douwenga

   14/10/2016 → 27/10/2016

   3 items of media coverage

   Press/Media: Research › Academic

View all (6) »

1. Dutch Neuroscience Meeting 2019

   Ulrich Eisel (Chair), Martina Schmidt (Chair)

   20-Jun-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

2. Dutch Neuroscience meeting 2018

   Amalia Dolga (Chair), Ulrich Eisel (Chair), Diana Esquivel Franco (Chair), Danielle Houwing (Chair), Martien Kas (Chair)

   7-Jun-2018 → 8-Jun-2018

   Activity: Participating in or organising an event › Organising an event › Academic

3. Targeting tumor necrosis factor receptors in neurodegeneration: Essential role for TNFR 2 signalling

   Ulrich Eisel (Invited speaker)

   8-Apr-2016

   Activity: Talk or presentation › Professional

View all (19) »